Research and Markets: Get the Latest Data on Eli Lilly's R&D Pipeline Products.
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c19665) has announced the addition of Eli Lilly Cancer Company Intelligence Report to their offering
Founded in 1876, Eli Lilly is a research-based company engaged in the discovery, development, manufacture
Information provided in this profile includes:
- Summary: At a glance review of agreements, products and R&D pipeline.
- Overview: Background, ownership structure and research techniques they have developed for drug discovery.
- Agreements: Key details of who the company is collaborating with, and on what.
- Product Portfolio: Product monographs, mechanism of action and indications approved and in development.
- R&D Pipeline: Concise summaries of products in research covering status, indication and clinical trials.
- Financials: An analysis of financial performance including P&L, R&D expenditure and funding.
For more information visit http://www.researchandmarkets.com/reports/c19665
In addition, make sure to read these articles:
- Research and Markets: This Report Examines In DetailThe Future Prospects For The Animal...
- Virbac Appoints Dr. Susan L. Longhofer Vice President of R&D.
- Intervet Acquires New R&D Facilities in the UK;Purchase Will Further Strengthen...
- Research and Markets: Get the Latest Data on the Utilities Market in the Asia-Pacific.
- Research and Markets: Get the Latest Data on Why Consumers Buy and How to Influence their...
- Research and Markets: View the Latest Data on Skateboarder Behaviours and Trends.
- FDA Informs Lilly of Its Overall Manufacturing Assessment.
- Research and Markets: Study the Latest Data on Waveriding Trends.
- Research and Markets: Study of the Latest Data on Waveriding Trends.
- Research and Markets: Get the Latest Data and Figures Relating to the UK Chilled Yoghurts...
- Research and Markets: Explore the Development of Altanas Major Therapeutic Franchises and...
- Research and Markets: Explore the Development of Altanas Major Therapeutic Franchises and...
- Scios and Lilly enter agreement for Alzheimer'sdisease research.
- Research and Markets: The Handbook on Alliances & Deals in Biotech Business: 50% of...
- By 2015 the Global Antiarrhythmic Market will be Worth $3.5 Billion, with Sales of...
Email
Digg It
del.icio.us
Related Resources
Related Articles
- Corporate research and venture capital can learn from each other: an on-going relationship between a large corporate research organization and a leading venture capital firm has provided complementary...
- Developing New Products
- Another phase of Novartis Animal Vaccines, Inc.'s purchase of ImmTech Biologics and Grand Laboratories is complete. (Marketing News).
Business Resources
Sponsored Links
Site Map | Contact Us | FAQs | About Us | Media Kit | Reprints | RSS Directory | Sign Up for Free Newsletters | Disclosure Policy
Copyright © 1999 - 2008 AllBusiness.com, Inc. All rights reserved.
No part of this content or the data or information included therein may be reproduced,
republished or redistributed without the prior written consent of AllBusiness.com.
Use of this site is governed by our Copyright and Intellectual Property Policy, Terms of Use Agreement and Privacy Policy.
© COPYRIGHT 2005 Business Wire
You may not repost, republish, reproduce, package and/or redistribute the content of this page,
in whole or in part, without the written permission of the copyright holder.
Online Business Database | Online Business Information | Email Marketing Lists | Sales and Marketing Solutions | Business Mailing Lists
AllBusiness.com, its parent company D&B, and its affiliates.
